Biotech News
Zura Bio Announces Proposed Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
investors.zurabio.com2026-05-06 15:06 EST
HENDERSON, Nev. --(BUSINESS WIRE)--Feb. 24, 2026-- Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced